XC8 100 mg

DRUG2 trials

Sponsors

PHARMENTERPRISES LLC, Chemlmmune Therapeutics LLC

Conditions

Acute Respiratory InfectionBronchial AsthmaEosinophilic AsthmaInfluenza

Phase 2

XC8 in the Treatment of Patients With Acute Respiratory Viral Infection

CompletedNCT03441373

PHARMENTERPRISES LLCAcute Respiratory Infection, Influenza

Start: 2016-02-03End: 2017-02-09Updated: 2018-02-23

XC8 in the Treatment of Patients With the Eosinophilic Phenotype of Bronchial Asthma

CompletedNCT04674137

Chemlmmune Therapeutics LLCBronchial Asthma, Eosinophilic Asthma

Start: 2020-12-16End: 2021-08-27Updated: 2021-09-22